BCL2 and rectal cancer: In turn, Gli is target of translocation or amplification in either breast and colorectal cancers [28], Bcl2 is amplified in squamous cell lung cancers [32] and the Wnt signaling pathway is altered in  of all colon and rectal cancer [33].